Evidence map›Paper›PMID 38390777›Full record

ArticleMolecular imaging and radionuclide therapy2024

Metastatic Superscan in

Man Mohan Singh, Shashwat Verma, Lavish Kakkar, Satyawati Deswal, Priyamedha Bose Thakur

Open access · diamondAbstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Man Mohan SinghDr. Ram Manohar Lohia Institute of Medical Sciences, Department of Nuclear Medicine, Lucknow, India.ORCID 0000-0001-9153-4697
Shashwat VermaDr. Ram Manohar Lohia Institute of Medical Sciences, Department of Nuclear Medicine, Lucknow, India.ORCID 0000-0003-3283-3798
Lavish KakkarDr. Ram Manohar Lohia Institute of Medical Sciences, Department of Nuclear Medicine, Lucknow, India.ORCID 0000-0002-8134-8425
Satyawati DeswalDr. Ram Manohar Lohia Institute of Medical Sciences, Department of Nuclear Medicine, Lucknow, India.ORCID 0000-0003-2684-0385
Priyamedha Bose ThakurDr. Ram Manohar Lohia Institute of Medical Sciences, Department of Nuclear Medicine, Lucknow, India.ORCID 0000-0002-2143-9667
Dr. Ram Manohar Lohia Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A biopsy-proven patient with prostate carcinoma aged 70 years was referred to the department of nuclear medicine for radionuclide-based therapy. His prostate-specific antigen levels were >1000 ng/mL, and prostatic magnetic resonance imaging showed an enlarged prostate with a heterogeneous signal and size 3.8x3.7x3.5 cm with few small heterogeneous nodular signals in the transition zone. He was scheduled for

Indexed as

18F prostate-specific membrane antigen18F PSMA PET/CTprostate carcinomaSuperscan

Identifiers

PMID38390777
PMCPMC10899739
OpenAlexW4392110059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.